Steven D. Spence is Director at HEMISPHERX BIOPHARMA INC (HEB). They have made 1 open-market trade across 1 company since 2006, most recently 2007-04-04.
CIK 0001323704
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $103K since 2006, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HEB | 209,410 | $377K |
Shares reported on the most recent Form 4, priced at the 2007-04-09 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HEB | BUY | 2006-12-05 | 2006-12-05 | $2.15 | $103K | -13.3% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.